<DOC>
	<DOCNO>NCT01797432</DOCNO>
	<brief_summary>The investigator hypothesize Restylane速 could serve repair matrix also maintain IL triamcinolone acetonide concentration high level longer period time skin , give sustained local anti-inflammatory effect thus , arrest AA process promote hair regrowth . Furthermore , combination Restylane速 IL triamcinolone acetonide injection may prevent common side effect , atrophy . With prevention scalp atrophy preservation high concentration triamcinolone acetonide long period time , patient may see good clinical response longer period time . Quality life may improve number clinic visit decrease would number IL corticosteroid injection .</brief_summary>
	<brief_title>Combined Restylane Triamcinolone Acetonide Injections Treatment Alopecia Areata</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1 . Men woman age 18 great . 2 . Alopecia areata diagnosis last two year extensive scalp involvement , 74 % 99 % , alopecia areata must involve leave right hemisphere scalp . 3 . Willing abstain use counter product prescription product , study medication , may promote hair growth . 4 . Willing abstain use nonsteroidal antiinflammatory medication , aspirin , St. Johns Wart , high dos Vitamin E supplementation . 5 . Subjects capable give informed consent . 6 . Willing adhere protocol , include scalp examination photography . 1 . Allergy intolerance Restylane速 hyaluronate preparation 2 . Allergy intolerance triamcinolone acetonide , 10 mg/cc . 3 . Underlying disease might adversely affected Restylane速 triamcinolone ( ex . patient bleed disorder ) . 4 . Immunosuppressed patient ( history transplantation , cancer , chemotherapy , splenectomy , HIV ) . 5 . Pregnant lactate female . 6 . Application topical immunomodulatory immunosuppressive agent precede 6 week . 7 . Systemic administration corticosteroid systemic treatment ( i.e . prednisone ) immunomodulatory immunosuppressive mechanism action , precede 8 week . 8 . Clinical evidence secondary skin infection ( i.e. , folliculitis ) . 9 . Other inflammatory infectious skin disease might interfere evaluation study . 10 . Investigational medication within past 30 day . 11 . Patients susceptibility keloid formation . 12 . Severe allergy manifest history anaphylaxis , history presence multiple severe allergy 13 . Patients allergies gram positive bacterial protein 14 . Unable give consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>